Beckman Coulter Launches Fully Automated DxU 1800 Urinalysis System at ADLM 2026 to Address Rising Testing Demand
核心洞察
Beckman Coulter Diagnostics (搜索) announced the U.S. launch of the DxU 1800 System, a fully automated urinalysis platform unveiled at the ADLM 2026 Annual Scientific Meeting & Clinical Lab Expo.
The integrated system combines a new DxU 1800c Chemistry analyzer with DxU Iris Microscopy technology, reducing manual microscopic review rates to less than 3%.
The DxU 1800c Chemistry analyzer can process up to 300 samples per hour with storage capacity for 2,000,000 samples and 100,000 strip images.
Beckman Coulter Diagnostics (搜索), a Danaher (搜索) company and global leader in clinical diagnostics, today announced the U.S. launch of the DxU 1800 System, a fully automated urinalysis solution that combines a new chemistry analyzer and consumables with proven microscopy technology. Unveiled at the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting & Clinical Lab Expo in July 2026, the system is designed to help laboratories deliver standardized results at scale, enabling clinicians to move from testing to decision making with confidence.
"Despite urinalysis's essential role and growing volume trends, many laboratories still rely on workflows requiring manual review, fragmented processes or separate chemistry and microscopy systems," said Matthew Rhyner, Vice President and Managing Director, Hematology and Urinalysis Business for Beckman Coulter Diagnostics (搜索). "As testing shifts to larger core and reference labs, these inefficiencies can create bottlenecks, variability and staffing strain. The DxU 1800 System helps standardize testing, increase throughput and reduce manual microscopy, empowering laboratories to deliver consistent results that enable confident clinical decisions at scale."
Rising Diagnostic Demand Across Care Settings
Urinalysis is among the most widely utilized diagnostic tests across care settings. In United States emergency departments, roughly one in three patient visits include a urine test, and nearly half of admissions involve urinalysis. In non-acute care, up to 87% of primary care patients receive urine testing, with urinalysis consistently ranking among the top 10 most ordered tests, underscoring its critical role in timely triage, diagnosis, and patient management.
The growing burden of chronic conditions is further driving testing volumes. In the United States, diabetes (搜索) prevalence has more than doubled over the past 50 years, now affecting 12% of the population, while chronic kidney disease (搜索) (CKD) prevalence has steadily increased to nearly 14–15% of adults. At the same time, urinary tract infections (搜索) (UTIs) continue to drive nearly 10 million clinical encounters annually, with recent trends showing more severe outcomes. Together, these factors are increasing testing demand and expanding urinalysis use across care settings.
Integrated Platform for Workflow Efficiency
As part of Beckman Coulter Diagnostics (搜索)' connected ecosystem, the DxU 1800 System combines the new DxU 1800c Chemistry analyzer with a DxU Iris Microscopy analyzer to deliver a fully automated, integrated urinalysis platform. These technologies unify chemical analysis and particle imaging within a single high-throughput system, helping laboratories scale operations with greater consistency and control.
The integrated solution streamlines end-to-end urinalysis by reducing manual handoffs and enabling more standardized workflows across chemistry and microscopy. By automating and connecting these processes, the DxU 1800 System leverages the DxU Iris automated urinalysis solution to reduce manual microscopic review rates to less than 3%, helping laboratories improve throughput, reduce variability, and redeploy staff to higher-value tasks.
Chemistry Analyzer Performance and Planned Menu Expansion
As a standalone analyzer, the DxU 1800c Chemistry analyzer can process up to 300 samples per hour, supports expansive result storage of up to 2,000,000 samples and 100,000 strip images, and displays onscreen strip image results for easy review.
Additionally, an expanded chemistry menu is planned to include creatinine and microalbumin assays, which may provide additional kidney function insight as part of routine screening testing without requiring changes to existing laboratory workflow. This planned menu expansion is intended to support laboratories in enhancing kidney disease assessment and monitoring within existing urinalysis processes.
Beckman Coulter Diagnostics (搜索) is showcasing the DxU 1800 Urinalysis System at the Danaher (搜索) Booth (#3237) during the ADLM 2026 Annual Meeting. Together with fellow Danaher companies, Beckman Coulter Diagnostics is demonstrating how Danaher's connected ecosystem accelerates ideas to real-world impact, bringing together complementary technologies and expertise to advance laboratory innovation and improve patient care.